- ACAD has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $47.1 million.
- ACAD has traded 64,327 shares today.
- ACAD is up 3.1% today.
- ACAD was down 6.4% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in ACAD with the Ticky from Trade-Ideas. See the FREE profile for ACAD NOW at Trade-Ideas More details on ACAD: ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders. Currently there are 6 analysts that rate ACADIA Pharmaceuticals a buy, no analysts rate it a sell, and 1 rates it a hold. The average volume for ACADIA Pharmaceuticals has been 1.2 million shares per day over the past 30 days. ACADIA has a market cap of $3.3 billion and is part of the health care sector and drugs industry. The stock has a beta of 2.88 and a short float of 29.3% with 11.14 days to cover. Shares are up 29% year-to-date as of the close of trading on Monday.